Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes

Movement Disorders

Volumn 21, Issue SUPPL. 14, 2006, Pages

  Kleiner Fisman, Galit ^a   Herzog, Jan ^b   Fisman, David N ^c   Tamma, Filippo ^d   Lyons, Kelly E ^e   Pahwa, Rajesh ^e   Lang, Anthony E ^f   Deuschl, Günther ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c PRINCETON UNIVERSITY   (United States)

^d SAN PAOLO HOSPITAL   (Italy)

^e UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^f TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Deep brain stimulation; Meta analysis; Outcome; Parkinson's disease; Subthalamic nucleus; Systematic review

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

BIBLIOGRAPHIC DATABASE; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG RESPONSE; DYSKINESIA; FOLLOW UP; HUMAN; MEDICAL LITERATURE; MEDLINE; MENTAL DISEASE; META ANALYSIS; MOTOR PERFORMANCE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RATING SCALE; REGRESSION ANALYSIS; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT FAILURE; UNIVARIATE ANALYSIS;

DEEP BRAIN STIMULATION; DOPAMINE AGONISTS; DYSKINESIAS; HUMANS; LEVODOPA; PARKINSON DISEASE; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 33745854279     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20962     Document Type: Review

References (76)

1. Lang AE, Lozano AM. Parkinson's disease: first of two parts. N Engl J Med 1998;339:1044-1053.
2. Pahwa R, Wilkinson SB, Overman J, et al. Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up. J Neurosurg 2003;99:71-77.
3. Pillon B, Ardouin C, Damier P, et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 2000;55:411-418.
4. Valldeoriola F, Pilleri M, Tolosa E, et al. Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients. Mov Disord 2002;17:125-132.
5. Lezcano E, Gomez-Esteban JC, Zarranz JJ, et al. Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus. Eur J Neurol 2004; 11:451-454.
6. Tröster Al, Fields JA, Wilkinson S, et al. Effect of motor improvement on quality of life following subthalamic, stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 2003;80:43-47.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
8. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698-702.
9. Davey Smith G, Egger M. Going beyond the grand mean: sub-group analysis in meta-analysis of randomized trials. In: Egger M, editor. Systematic reviews in healthcare: meta-analysis in context. London: BMJ Publishing Group; 1995. p 143-156.
10. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-634.
11. Quality Standards Subcommittee and the Therapeutics and Technology Assessment Subcommittee. Clinical practice guideline process manual. St. Paul, MN: American Academy of Neurology; 2004.
12. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, et al., editors. Recent developments in Parkinson's disease, vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987. p 153-163.
13. Ecdeu GW. Abnormal Involuntary Movement Scale (AIMS). In: Assessment manual for psychopharmacology, rev. ed. Washington, DC: US Department of Health, Education, and Welfare; 1976.
14. Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13.
15. Ford B, Winfield L, Pullman SL, et al. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 2004;75: 1255-1259.
16. Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol 2005;252:583-588.
17. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201-207.
18. Just H, OStergaard K. Health-related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 2002;17:539-545.
19. Lagrange E, Krack P, Moro E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 2002;59:1976-1978.
20. Martinez-Martin P, Valldeoriola. F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002;17:372-377.
21. Patel NK, Plaha P, O'Sullivan K, et al. MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:1631-1637.
22. Spottke EA, Volkmann J, Lorenz D, et al. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic, nucleus. J Neurol 2002;249:759-766.
23. The Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
24. Kleiner-Fisman G, Fisman DN, Sime E, et al. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003;99: 489-495.
25. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
26. Ostergaard K, Sunde N, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 2002;17:693-700.
27. Welter ML, Houeto JL, du Tezenas MS, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-583.
28. Figueiras-Mendez R, Regidor I, Riva-Meana C, et al. Further supporting evidence of beneficial subthalamic stimulation in Parkinson's patients. Neurology 2002;58:469-470.
29. Herzog J, Volkmann J, Krack P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 2003;18:1332-1337.
30. Romito LM, Scerrati M, Contarino MF, et al. Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up. J Neurosurg Sci 2003;47:119-128.
31. Vesper J, Klostermann F, Stockhammer F, et al. Results of chronic subthalamic nucleus stimulation for Parkinson's disease: a 1-year follow-up study. Surg Neurol 2002;57:306-311.
32. Visser-Vandewalle V, Temel Y, van Der LC, et al. Deep brain stimulation in movement disorders: the applications reconsidered. Acta Neurol Belg 2004;104:33-36.
33. Lozano AM, Mahant N. Deep brain stimulation surgery for Parkinson's disease: mechanisms and consequences. Parkinsonism Relat Disord 2004;10(Suppl. 1):S49-S57.
34. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002; 59:932-934.
35. Simuni T, Jaggi JL, Mulholland H, et al. Bilateral stimulation of the subthalamic, nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg 2002;96:666-672.
36. Alkhani A, Lozano AM. Pallidotomy for parkinson disease: a review of contemporary literature. J Neurosurg 2001;94:43-49.
37. Binder DK, Rau G, Starr PA. Hemorrhagic complications of microelectrode-guided deep brain stimulation. Stereotact Funct Neurosurg 2003;80:28-31.
38. Favre J, Taha JM, Burchiel KJ. An analysis of the respective risks of hematoma formation in 361 consecutive morphological and functional stereotactic procedures. Neurosurgery 2002;50:48-56.
39. Terao T, Takahashi H, Yokochi F, et al. Hemorrhagic complication of stereotactic surgery in patients with movement disorders. J Neurosurg 2003;98:1241-1246.
40. Djindjian M, Fevrier MJ, Otterbein G, et al. Oxacillin prophylaxis in cerebrospinal fluid shunt procedures: results of a randomized open study in 60 hydrocephalic patients. Surg Neurol 1986;25: 178-180.
41. Quigley MR, Reigel DH, Kortyna R. Cerebrospinal fluid shunt infections. Report of 41 cases and a critical review of the literature. Pediatr Neurosci 1989;15:111-120.
42. Rieder MJ, Frewen TC, Del Maestro RF, et al. The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections. CMAJ 1987;136:935-938.
43. Shapiro S, Boaz J, Kleiman M, et al. Origin of organisms infecting ventricular shunts. Neurosurgery 1988;22:868-872.
44. Walters BC, Goumnerova L, Hoffman HJ, et al. A randomized controlled trial of perioperative rifampin/trimethoprim in cerebrospinal fluid shunt surgery. Childs Nerv Syst 1992;8:253-257.
45. Barichella M, Marczewska AM, Mariani C, et al. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation. Mov Disord 2003;18:1337-1340.
46. Macia F, Perlemoine C, Coman I, et al. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord 2004;19:206-212.
47. Iansek R, Rosenfeld JV, Huxbam FE. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Med J Aust 2002;177: 142-146.
48. Vingerhoets FJ, Villemure JG, Temperli P, et al. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002;58:396-401.
49. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:834-839.
50. Morrison CE, Borod JC, Perrine K, et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch Clin Neuropsychol 2004;19:165-181.
51. Trepanier LL, Kumar R, Lozano AM, et al. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn 2000;42:324-347.
52. Bekker AY, Weeks EJ. Cognitive function after anaesthesia. in the elderly. Best Pract Res Clin Anaesthesiol 2003;17:259-272.
53. Funkiewiez: A, Ardouin C, Krack P, et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord 2003;18:524-530.
54. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 2000;57:461-465.
55. Burkhard PR, Vingerhoets FJ, Berney A, et al. Suicide after successful deep brain stimulation for movement disorders. Neurology 2004;63:2170-2172.
56. Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002;17:1084-1085.
57. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:701-707.
58. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111.
59. Erola T, Karinen P, Heikkinen E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients. Parkinsonism Relat Disord 2005;11:89-94.
60. Goetz CG, Poewe W, Rascol O, et al. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord 2005;20:523-539.
61. Broggi G, Franzini A, Ferroli P, et al. Effect of bilateral subthalamic electrical stimulation in Parkinson's disease. Surg Neurol 2001;56:89-94.
62. Tamma F, Rampini P, Egidi M, et al. Deep brain stimulation for Parkinson's disease: the experience of the Policlinico-San Paolo Group in Milan. Neurol Sci 2003;24(Suppl. 1):S41-S42.
63. Tavella A, Bergamasco B, Bosticco E, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up. Neurol Sci 2002;23(Suppl. 2):S111-S112.
64. Thobois S, Mertens P, Guenot M, et al. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol 2002;249:529-534.
65. Molinuevo JL, Valldeoriola F, Tolosa E, et al. Levodopa with-drawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000;57:983-988.
66. Volkmann J, Allert N, Voges J, et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2001;56:548-551.
67. Krause M, Fogel W, Mayer P, et al. Chronic inhibition of the subthalamic nucleus in Parkinson's disease. J Neurol Sci 2004; 219:119-124.
68. Fraix V, Pollak P, Van Blercom N, et al. Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology 2000;55:1921-1923.
69. Jaggi JL, Umemura A, Hurtig HI, et al. Bilateral stimulation of the subthalamic nucleus in Parkinson's disease: surgical efficacy and prediction of outcome. Stereotact Funct Neurosurg 2004;82:104-114.
70. Rodriguez-Oroz MC, Zamarbide I, Guridi J, et al. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004;75:1382-1385.
71. Doshi PK, Chhaya NA, Bhatt MA. Bilateral subthalamic nucleus stimulation for Parkinson's disease. Neurol India 2003;51:43-48.
72. Lanotte MM, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002;72:53-58.
73. Voges J, Volkmann J, Allert N, et al. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg 2002;96:269-279.
74. Katayama Y, Kasai M, Oshima H, et al. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. J Neurosurg 2001;95:213-221.
75. Romito LM, Scerrati M, Contarino MF, et al. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002;58:1546-1550.
76. Krause M, Fogel W, Heck A, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001;70: 464-470.